| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 36.43▲ | 36.55▲ | 36.75▼ | 36.45▲ | 34.79▲ |
| MA10 | 36.39▲ | 36.96▼ | 37.21▼ | 35.90▲ | 33.74▲ |
| MA20 | 36.48▲ | 37.23▼ | 37.18▼ | 34.94▲ | 30.47▲ |
| MA50 | 36.85▼ | 36.46▲ | 35.93▲ | 33.20▲ | 29.89▲ |
| MA100 | 37.19▼ | 35.89▲ | 35.43▲ | 30.04▲ | 26.27▲ |
| MA200 | 37.26▼ | 35.36▲ | 34.46▲ | 29.72▲ | 29.59▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.044▲ | -0.182▼ | -0.194▼ | 0.154▲ | 0.666▲ |
| RSI | 55.564▲ | 45.143▼ | 50.083▲ | 60.640▲ | 72.347▲ |
| STOCH | 47.639 | 5.949▼ | 18.721▼ | 54.470 | 81.883▲ |
| WILL %R | -10.588▲ | -76.758▼ | -86.549▼ | -54.616 | -28.104 |
| CCI | 171.611▲ | -91.031 | -135.840▼ | 102.471▲ | 142.199▲ |
| ▼ RSI | $GMAB RSI(14) Crossed Below 70 | Set Alert |
|
Tuesday, October 06, 2026 04:08 AM
US pharma major AbbVie and Denmark’s Genmab late yesterday announced positive top-line results from the Phase III EPCORE DLBCL-2 trial evaluating fixed treatment duration epcoritamab.
|
|
Monday, October 05, 2026 12:55 PM
AbbVie (NYSE: ABBV) and Genmab A/S (Nasdaq: GMAB) today announced positive topline results from the Phase 3 EPCORE DLBCL-2 trial ...
|
|
Monday, October 05, 2026 12:55 PM
AbbVie (NYSE: ABBV) and Genmab A/S (Nasdaq: GMAB) today announced positive topline results from the Phase 3 EPCORE DLBCL-2 trial ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/10/26 | 37.28 | 37.87 | 36.27 | 36.65 | 4,253,684 |
| 06/10/26 | 39.11 | 39.15 | 37.07 | 37.80 | 6,595,862 |
| 05/10/26 | 35.09 | 40.17 | 35.02 | 38.48 | 12,403,391 |
| 02/10/26 | 34.39 | 35.02 | 33.725 | 34.75 | 5,436,232 |
| 01/10/26 | 35.25 | 35.80 | 34.515 | 34.55 | 6,377,008 |
| 30/09/26 | 35.72 | 35.905 | 35.37 | 35.675 | 5,154,339 |
| 29/09/26 | 34.94 | 35.64 | 34.89 | 35.57 | 3,827,540 |
| 28/09/26 | 34.76 | 35.70 | 34.63 | 35.36 | 2,794,571 |
| 25/09/26 | 34.95 | 35.47 | 34.70 | 35.32 | 3,583,077 |
| 24/09/26 | 34.69 | 35.03 | 34.36 | 34.83 | 2,514,937 |
|
|
||||
|
|
||||
|
|